PHGE
Biomx Inc
NYSE MKT: PHGE · HEALTHCARE · BIOTECHNOLOGY
$0.85
+34.07% today
Updated 2026-04-30
Market cap
$7.54M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-37.05
Dividend yield
—
52W range
$1 – $14
Volume
0.2M
Biomx Inc (PHGE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.34M | $-4.10M | $-30.00 | $-11.30M | $-17.58M | $-24.45M | $-27.57M | $-29.09M | $-21.29M | $-36.98M | $-26.39M |
| Capital expenditures | $98000.00 | $850000.00 | $0.00 | $137000.00 | $1.31M | $1.01M | $3.68M | $112000.00 | $50000.00 | $30000.00 | $2000.00 |
| Depreciation | $23000.00 | $95000.00 | — | $210000.00 | $318000.00 | $2.18M | $2.56M | $2.52M | $871000.00 | $1.80M | — |
| Stock-based comp | — | — | — | $951000.00 | $938000.00 | $2.89M | $3.24M | $1.53M | $1.06M | $1.85M | $2.09M |
| Free cash flow | $-1.43M | $-4.95M | $-30.00 | $-11.44M | $-18.89M | $-25.46M | $-31.25M | $-29.20M | $-21.34M | $-37.01M | $-26.39M |
| Investing cash flow | $-98000.00 | $-2.12M | — | $-30.04M | $19.74M | $-10.86M | $16.17M | $-2.11M | $1.95M | $715000.00 | — |
| Financing cash flow | $1.20M | $12.95M | $460.00 | $43.04M | $61.55M | $134000.00 | $37.28M | $292000.00 | $2.90M | $38.37M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $-35.17M | — | — | — | — | — |